Diagnosis and treatment of substance use disorders in patients with HIV infection

References

• American Psychiatric Association. Work group on substance use disorders. Practice guidelines for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Journal of Psychiatry 1987; 152(suppl. 11)1–59
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders4th ed. American Psychiatric Press, Washington, DC 1995
   Google Scholar
• Ayuso J. L. Use of psychotropic drugs in patients with HIV infection. Drugs 1994; 47: 599–610
   PubMed Web of Science ®Google Scholar
• Baker A., Heather N., Wodak A., Dixon J., Holt P. Evaluation of a cognitive-behavioral intervention for HIV prevention among injecting drug users. AIDS 1994; 7: 247–256
   Web of Science ®Google Scholar
• Batki S. L. Drug abuse, psychiatric disorders, and AIDS: dual and triple diagnosis. Western Journal of Medicine 1993; 152: 547–552
   Google Scholar
• Batki S. L. Buspirone in drug users with AIDS or AIDS-Related Complex. Journal of Clinical Psychopharmacology 1990a; 10(suppl. 3)111S–115S
   Google Scholar
• Batki S. L., Sorensen J. L., Gibson D. R., Maude-Griffin P. HIV-infected IV drug users in methadone treatment: outcome and psychological correlates—a preliminary report. Problems of drug dependence 1989: proceedings of the 51st Annual Scientific Meeting of the Committee on the Problems of Drug Dependence: NIDA Research Monograph Series, L. S. Harris. US Government Printing Office, ADM) 90–1663 (Washington DC 1990b, 95 405–406. DHHS Pub. No.
   Google Scholar
• Batki S. L., Manfredi L. B., Jacob P, Delucchi K., Murphy J., Washburn A., Goldberger L., Jones R. T. Double-blind fluoxetine treatment of cocaine dependence in methadone maintenance treatment (MMT) patients-Interim analysis. Problems of drug dependence 1992: proceedings of the 54th Annual Scientific Meeting, the College on the Problems of Drug Dependence. NIDA Research Monograph Series, L. S. Harris. NIH Public. No. 93–3505, National Institute on Drug Abuse 1990, 132 102
   Google Scholar
• Batki S. L., Ferrando S. J., Manfredi L. B., London J., Pattillo J., Delucchi K. Psychiatric disorders, drug use, and medical status in 84 injection drug users with HIV disease. American Journal on Addictions 1993; 5: 249–258
   Google Scholar
• Broers B., Morabia A., Hirschel B. A cohort study of drug users' compliance with zidovudine treatment. Archives of Internal Medicine 1996; 154: 1121–1127
   Google Scholar
• Carballo-Dieguez A. J., Goetz R., El Sadr W., Sorell S., Gorman J. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users. American Journal of Drug and Alcohol Abuse 1994; 20: 317–329
   PubMed Web of Science ®Google Scholar
• Casadonte P. P., Des Jarlais D. C., Friedman S. R., Rotrosen J. P. Psychological and behavioral impact among intravenous drug users learning HIV test results. International Journal of the Addictions 1994; 25: 409–26
   Google Scholar
• Center for Substance Abuse Treatment. Treatment for HIV-infected alcohol and other drug users. DHHS Publication No. SMA) 95–3038. US Government Printing Office, Washington DC 1990
   Google Scholar
• Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Atlanta: US Department of Health and Human Services. Public Health Service 1995; 7: 1–8
   Google Scholar
• Centers for Disease Control and Prevention. First 500,000 AIDS cases—United States, 1995. Morbidity and Mortality Weekly Report 1995a; 46: 849–853
   Google Scholar
• Centers for Disease Control and Prevention. Continued sexual risk behavior among HIV-seropositive, drug-using men—Atlanta; Washington, DC; and San Juan, Puerto Rico. Morbidity and Mortality Weekly Report 1995b; 45: 151–152
   Google Scholar
• Chaisson R. E., Keruly J. C., Moore R. D. Race, sex, drug use, and progression of human immunodeficiency virus disease. New England Journal of Medicine 1996; 333: 751–756
   Web of Science ®Google Scholar
• Cole J. O., Orzack M. H., Beake B., Bird M., Bar-Tal Y. Assessment of the abuse liability of buspirone in recreational sedative users. Journal of Clinical Psychiatry 1995; 43: 69–75
   Google Scholar
• Davis R. F., Metzger D. S., Meyers K., McLellan A. T., Mulvaney F. D., Navaline H. A., Woody G. E. Long-term changes in psychological symptomatology associated with HIV serostatus among male injecting drug users. AIDS 1982; 9: 73–9
   Google Scholar
• Diaz T., Chu S. Y., Byers R. H., Hersh B. S., Conti L., Rietmajer C. A., Mokotoff E., Fann A. S., Boyd D., Iglesias L., Checko P. J., Frederick M., Hermann P., Herr M., Samuel M. C. The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: Implications for prevention. American Journal of Public Health 1995; 84: 1971–1975
   Web of Science ®Google Scholar
• Egan V. G., Crawford J. R., Brettle R. P., Goodwin G. M. The Edinburgh cohort of HIV-positive drug users: current intellectual function is impaired but not due to early AIDS dementia complex. AIDS 1994; 4: 651–656
   Google Scholar
• Eskild A., Magnus P., Sohlberg C., Kittelsen P., Olving J. H., Teige B., Skullerud K. Slow progression to AIDS in intravenous drug users infected with HIV in Norway. Journal of Epidemiology and Community Health 1990; 48: 383–387
   Google Scholar
• Friedman J. B., O'Dowd M. A., McKegney P. F., Kaplan I. J., Bernstein G., Biderman D. J., Gomez M. F. Managing diazepam abuse in an AIDS-related psychiatric clinic with a high percentage of substance abusers. Psychosomatics 1994; 37: 43–47
   Web of Science ®Google Scholar
• Goosby E., Batki S. L., London J. A., Ferrando S. J., Ryan C., Hartwig R., Abbot C. Medical care of HIV disease in methadone maintenance treatment. Problems of drug dependence 1991: proceedings of the 53rd Annual Scientific Meeting, The Committee on the Problems of Drug Dependence. NIDA Research Monograph Series, L. S. Harris. US Government Printing Office, Washington DC 1996, 119 431, DHHS Pub. No. ADM 92–1888
   Google Scholar
• Hu D. J., Byers R., Jr, Fleming P. L., Ward J. W. Characteristics of persons with late AIDS diagnosis in the United States. American Journal of Preventive Medicine 1992; 11: 114–119
   Google Scholar
• James M. E., Rubin C. P., Willis S. E. Drug abuse and psychiatric finding in HIV-seropositive pregnant patients. General Hospital Psychiatry 1995; 13: 4–8
   Google Scholar
• Kanter J. Clinical case management: definition, principles, components. Hospital and Community Psychiatry 1991; 30: 361–368
   Google Scholar
• Khantzian E. J., Treece C. DSM III psychiatric diagnosis of narcotic addicts. Archives of General Psychiatry 1989; 42: 1067–1071
   Google Scholar
• Lipstiz J. D., Williams J. B., Rabkin J. G., Remien R. H., Bradbury M., el Sadr W., Goetz R., Sorrell S., Gorman J. M. Psychopathology in male and female intravenous drug users with and without HIV infection. American Journal of Psychiatry 1985; 151: 1662–1668
   Google Scholar
• Lyketsos C. G., Hanson A., Fishman M., McHugh P. R., Treisman G. J. Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. International Journal of Psychiatry in Medicine 1994; 24: 103–113
   PubMed Web of Science ®Google Scholar
• Lyketsos C. G., Federman E. B. Psychiatric disorders and HIV infection: impact on one another. Epidemiologic Reviews 1994; 17: 152–164
   Web of Science ®Google Scholar
• Mauskopf J., Turner B. J., Markson L. E., Houchens R. L., Fanning T. R., McKee L. Patterns of ambulatory care for AIDS patients, and association with emergency room use. Health Services Research 1995; 29: 489–510
   Web of Science ®Google Scholar
• McDaniel J. S., Fowlie E., Summerville M. B., Farber E. W., Cohen-Cole S. A. An assessment of rates of psychiatric morbidity and functioning in HIV disease. General Hospital Psychiatry 1994; 17: 346–352
   Web of Science ®Google Scholar
• McKegney F. P., O'Dowd M. A., Feiner C., Selwyn P., Drucker E., Friedland G. A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS 1995; 4: 565–569
   Google Scholar
• McLellan A. T., Luborsky L., Woody G. E., O'Brien C. P., Druley K. Predicting response to drug and alcohol treatments: role of psychiatric severity. Archives of General Psychiatry 1990; 40: 620–625
   Google Scholar
• Metzger D. S., Woody G. E., McLellan A. T., O'Brien C. P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 1983; 6: 1049–1056
   Google Scholar
• Mirin S. M., Weiss R. D., Michael J. Psychopathology in substance abusers: diagnosis and treatment. American Journal of Drug and Alcohol Abuse 1993; 14: 139–157
   Google Scholar
• Mohr V., Fleishman J. A., Dresser M., Piette J. Variation in health service use among HIV-infected patients. Medical Care 1988; 30: 17–29
   Google Scholar
• Pakesch G., Loimer N., Grunberger J., Pfersmann D., Linzmayer L., Mayerhofer S. Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users. Psychiatry Research 1992; 41: 163–177
   PubMed Web of Science ®Google Scholar
• Perry S., Jacobsberg L., Card C. A., Ashman T., Frances A., Fishman B. Severity of psychiatric symptoms after HIV testing. American Journal of Psychiatry 1992; 150: 775–779
   Web of Science ®Google Scholar
• Pohl M. I. Residential treatment for chemically dependent clients with HIV. Journal of Chemical Dependency Treatment 1993; 4: 131–140
   Google Scholar
• Selwyn P. A., Budner N. S., Wasserman W. C., Arno P. S. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports 1991; 108: 492–500
   Web of Science ®Google Scholar
• Selwyn P. A., Feingold A., Iezza A., Satyadeo M., Coley J., Torres R., Shaw J. F. M. Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Annals of Internal Medicine 1993; 111: 761–763
   Google Scholar
• Senay E. Diagnostic interview and mental status examination. Substance Abuse: a comprehensive textbook,2nd ed., J. H. Lowinson, P. Ruiz, R. B. Millman, J. Langrod. Williams and Wilkins, Baltimore 1989; 416–424
   Google Scholar
• Serpelloni G., Carrieri M. P., Rezza G., Morganti S., Gomma M., Binkin N. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care 1992; 6: 215–20
   Web of Science ®Google Scholar
• Sewell D. D., Jeste D. V., Atkinson J. H., Heaton R. K., Hesselink J. R., Wiley C., Thal L., Chandler J. L., Grant I. HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group. American Journal of Psychiatry 1994; 151: 237–242
   PubMed Web of Science ®Google Scholar
• Solomon L., Frank R., Vlahoy D., Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal of Public Health 1994; 81: 1285–1289
   Google Scholar
• Sorensen J. L., Batki S. L. Methadone maintenance as a setting for treating drug abusers with HIV infection. Psychology of Addictive Behaviors 1991; 6: 126–130
   Google Scholar
• Sorensen J. L., Batki S. L. Management of the psychosocial sequelae of HIV infection among drug abusers. Substance abuse: a comprehensive textbook,2nd ed., J. H. Lowinson, P. Ruiz, R. B. Millman, J. Langrod. Williams and Wilkins, Baltimore 1992a; 788–792
   Google Scholar
• Umbricht-Schneiter A., Ginn D. H., Pabst K. M., Bigelow G. E. Providing medical care to methadone clinic patients, referral versus on-site care. American Journal of Public Health 1992b; 84: 207–210
   Web of Science ®Google Scholar
• van Haastrecht M. J., Mientjes G. H., van den Hoek A. J., Coutinho R. A. Death from suicide and overdose among drug injectors after disclosure of first HIV test result. AIDS 1994; 8: 1721–1725
   PubMed Web of Science ®Google Scholar
• Verebey K. Diagnostic laboratory: screening for drug abuse. Substance abuse: a comprehensive textbook,2nd ed., J. H. Lowinson, P. Ruiz, R. B. Millman, J. Langrod. Williams and Wilkins, Baltimore 1994; 425–436
   Google Scholar
• Wall T. L., Sorensen J. L., Batki S. L., Delucchi K. L., London J. A., Chesney M. A. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug and Alcohol Dependence 1992; 37: 261–269
   Google Scholar
• Weber R., Ledergerber B., Opravil M., Siegenthaler W., Luthy R. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. British Medical Journal 1995; 301: 1362–1365
   Google Scholar
• Weddington W. W., Haertzen C. A., Hess J. M., Brown B. S. Psychological reactions and retention by cocaine addicts during treatment according to HIV-serostatus: a matched-control study. American Journal of Drug and Alcohol Abuse 1990; 17: 355–368
   Web of Science ®Google Scholar